About GlyProVac
GlyProVac is pursuing the development of a glycoprotein based vaccine against Enterotoxigenic Escherichia coli (ETEC).
GlyProVac is pursuing the development of a glycoprotein based vaccine against Enterotoxigenic Escherichia coli (ETEC).
Company Highlights
Year Founded
2018
Employees
10
Location (HQ)
DNK
Since Last Funding
6 months
Monthly Website Visitors
219
Total Investment Amt
$500K
Last Funding Round
Grant
YoY Headcount Growth
24.69%
Key Metrics
Senior Hires
Name | Linkedin Profile | Position | Date Joined |
---|---|---|---|
John Doe | https://www.linkedin.com/in/johndoe | CEO | CEO |
Jane Doe | https://www.linkedin.com/in/janedoe | CTO | CTO |
John Smith | https://www.linkedin.com/in/johnsmith | CFO | CFO |
Jane Smith | https://www.linkedin.com/in/janesmith | COO | COO |
Similar Companies
- Transgene BiotekAdvanced EnzymesEnGeneICBharat BiotechCytoGenixEpsilon PharmaceuticalsGreenwell BiotechCyGenicaECOSTP TechnologiesEnaltec LabsVir BiotechnologyVaxcyteVirpax Pharmaceuticals Inc.EnBiotixGeltorAffinivaxPeptilogicsEGenesisEncoded TherapeuticsIcosavaxProvention BioOncoPepGenEditAlloVirPalleon PharmaceuticalsSpero TherapeuticsCodagenixGenprexEvozyneElicio TherapeuticsGRO BiosciencesVirus Geeks Inc.Meissa VaccinesImvaxRational VaccinesContraFectTentarix BiotherapeuticsEntasis TherapeuticsJust - Evotec BiologicsInventpriseEiger BioPharmaceuticalsGeneos TherapeuticsOerth BioGigaGenAttivare TherapeuticsTavotek BiotherapeuticsEnochian BioSciencesInvectys TherapeuticsGrove BiopharmaE25Bio
Biotechnology Research
- Ousia PharmaAdaptVacAVA Genomics ConsultancyInitiator PharmaUpfront Chromatography A/SSolid TherapeuticsEmbark BiotechAQuantumCytoki PharmaCell2Cure ApSatSpiroCerCell A/SHealthycrop.worldAida OncologyVarCT DiagnosticsTetraKit TechnologiesTriptoBIOLophoraGLX ANALYTIXMELLOTruust NeuroimagingSynobodyCytoVacScandion OncologyProbmetbioviceCambioticsMyco4FoodBiomcareBioScavengeBioHaloTailwind BiotechLoma TherapeuticsLOma TherapeuticsVAR2 PharmaceuticalsStimuliverAlcolaseClutch NutritionomiicsThe Fermentation Based Biomanufacturing InitiativePond Biomaterials
Biopharma